GENOME ANNOUNCEMENT
===================

*Gluconobacter oxydans*, an obligate aerobic, Gram-negative, and rod-shaped acidophilic organism that belongs to the family *Acetobacteriaceae*, is known for its incomplete oxidation of a wide range of carbohydrates and alcohols ([@B1]). The corresponding products (aldehyde, ketone, and organic acid) are excreted almost completely into the medium. *G. oxydans* strains can be used industrially to produce [l]{.smallcaps}-sorbose from [d]{.smallcaps}-sorbitol; [d]{.smallcaps}-gluconic acid, 5-ketogluconic acid, and 2-ketogluconic acid from [d]{.smallcaps}-glucose; dihydroxyacetone from glycerol; and 6-amino-[l]{.smallcaps}-sorbose from 1-amino-[d]{.smallcaps}-sorbitol for the synthesis of Miglitol ([@B1][@B2][@B3]). The complete genome sequence of *G. oxydans* 621 H (DSM 2343) is publicly available ([@B3]). The genome data provide useful information for metabolic reconstruction of the pathways leading to some industrially important products derived from alcohols and sugars.

*G. oxydans* can also be employed for the enantioselective oxidation of different racemic primary alcohols for the production of enantiomerically pure carboxylic acids ([@B2]). In previous studies, *G. oxydans* DSM 2003 efficiently catalyzed racemic 1,2-propanediol and racemic 1,2-butanediol into (*R*)-lactic acid and (*R*)-2-hydroxybutyric acid, respectively ([@B4], [@B5]). (*R*)-Lactic acid and (*R*)-2-hydroxybutyric acid are important building blocks for the production of 2-oxo-carboxylates, biodegradable material, glycols, halo esters, and epoxides ([@B6][@B7][@B9]). These compounds are important intermediates of pharmaceuticals ([@B9][@B10][@B11]). To better understand the biocatalytic process of *G. oxydans* DSM 2003 and to further improve its biotechnological applications, we sequenced the genome of the strain.

The draft genome sequence of *G. oxydans* DSM 2003 was obtained using the Illumina GA system; sequencing was performed by the Chinese National Human Genome Center at Shanghai, China, with a paired-end library. The reads were assembled by using the Velvet software ([@B12]). The genome was annotated using the Rapid Annotations using Subsystems Technology (RAST) automated annotation server ([@B13]). The G+C content was calculated using the genome sequence. The functional description was determined by using Clusters of Orthologous Genes ([@B14]). The rRNA and tRNA genes were identified by RNAmmer 1.2 ([@B15]) and tRNAscan-SE ([@B16]), respectively.

The draft genome sequence of DSM 2003 has a G+C content of 60.9%. The number of contigs (\>100 bp) was 147, and the number of bases was 2,938,182. There are 2,792 putative coding sequences (CDS) (935 bp average length), 50 tRNA genes, and 2 rRNA operons in the genome sequence. The coding percentage is 67.8%, and 1,892 CDS have predicted functions.

There are 363 subsystems represented in the draft genome sequence. The genes encoding proteins responsible for enantioselective oxidation of racemic 1,2-propanediol for the production of (*R*)-lactic acid were successfully annotated. Several annotated NAD-independent lactate dehydrogenase genes, which might play important roles in 2-hydroxy-carboxylate oxidation ([@B17][@B18][@B19]), were also annotated. The obtained genome sequence provides useful hints for strain improvement; for example, the annotated NAD-independent lactate dehydrogenase genes provide targets for gene knockout to further improve the yield of final (*R*)-lactic acid and (*R*)-2-hydroxybutyric acid production by *G. oxydans* DSM 2003*.*

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. [AYTY00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AYTY00000000). The version described in this paper is the first version, with accession no. AYTY01000000.
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